Navigation Links
Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease

WASHINGTON--(BUSINESS WIRE)--May 22, 2007 - Alequel(TM), an individualized oral immune regulation preparation, may be an effective treatment for moderate-to-severe Crohn's disease. Interim data from two ongoing double-blind, placebo controlled Phase II studies suggest that this investigational approach induced good clinical remissions and improved patients' quality of life compared to placebo. Medical researchers from Hebrew University-Hadassah Medical Center, Jerusalem, Israel, will today present clinical trial results at Digestive Disease Week 2007, the largest international gathering of academic researchers and practicing physicians in gastrointestinal (GI) specialties, held this year in Washington, DC. The trials were sponsored by Enzo Therapeutics, Inc., a wholly owned subsidiary of Enzo Biochem, Inc. (NYSE:ENZ).

"Given our current understanding of Crohn's disease as an inappropriate autoimmune response in the GI tract, we are developing Alequel as an individualized oral treatment that harnesses the patient's own immune system to alleviate symptoms," said Gary C. Cupit, PharmD, President of Enzo Therapeutics. "Many Crohn's patients are frustrated with current treatment options; Alequel is designed to reduce patients' dependence on systemic immunosuppressant drugs. The interim Phase II results encourage us to advance beyond these two studies presented this week at DDW. Thus, we are planning to expand into more advanced studies in the United States."

About the Clinical Studies

These two double-blind, placebo-controlled studies randomized 49 subjects with moderate-to-severe Crohn's disease as measured by the Crohn's Disease Activity Index (CDAI). Alequel(TM) therapy consists of oral administration of an autologous protein-containing extract, individually prepared from mucosal tissue colon biopsies of the subject obtained through colonoscopy (a common procedure for Crohn's patients). In one trial
'"/>




Page: 1 2 3

Related medicine technology :

1. Researchers Discover Method for Identifying How Cancer Evades the Immune System
2. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
3. Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency
4. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
5. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
6. CytImmune Presents Positive CYT-6019 Data During the American Society of Clinical Oncology Annual Meeting in Chicago
7. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
8. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
9. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
10. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
11. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
Post Your Comments:
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- Market Research Report on Global ... a professional and in-depth market survey on ... The report firstly reviews the basic information of ... manufacturing technology. The report then explores global and ... their product specification, capacity, Production value, and market ...
(Date:8/29/2014)... N.C. , Aug. 29, 2014 The ... of regulatory and marketplace changes. CI leaders who adjust ... In a new Best Practices, LLC study ... of actionable insights, including: - Use secondary ... than primary research - Internal staff who ...
(Date:8/29/2014)... 2014  A Boston Scientific Corporation (NYSE: ... removability and preliminary long term stricture resolution of ... August issue of the peer-reviewed journal, Gastroenterology. ... being conducted in 11 countries and five continents, ... stents (FCSEMS) after extended indwell (i.e., up to ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4
... FRANKLIN LAKES, N.J. , May 11 ... agonists (LABAs) alone, and not in combination with other ... Food and Drug Administration (FDA) on the risk of ...  This according to a new study from the ...
... , May 11 The DNA Medicine Institute announced today ... from the Bill & Melinda Gates Foundation.  The grant will support an ... M.D. titled "Optomagnetic Finger Scanner for Malaria." , ... Dr. Chan,s project is one of 78 grants announced ...
Cached Medicine Technology:Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 2Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 3Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 4Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations 5DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 2DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research 3
(Date:9/1/2014)... 2014 Liver is the largest organ inside ... helps the body in barring itself from poisons, helps in ... Liver also plays many important functions such as protein production, ... , Many illnesses can affect the liver, an organ the ... on the right side of the abdomen, reducing its capabilities ...
(Date:9/1/2014)... Los Angeles (PRWEB) September 01, 2014 ... fluctuations. These hormonal daily changes begin as early ... most of their lives negotiating the ups and downs ... skinny or thin or even healthy sizes seems to ... daily. As a woman in her 40's begin ...
(Date:9/1/2014)... atrial fibrillation (AF) doubles the risk of stroke compared ... 6 000 patients presented at ESC Congress today by ... a simple clinical assessment of the type of AF ... Ischaemic stroke is the second cause of death in ... many more disabled patients each year. Annual direct health ...
(Date:9/1/2014)... Albany, New York (PRWEB) September 01, 2014 ... to store, retrieve, organize and analyze biological and ... comprises of the activity of developing software tools ... is not to be confused with biological computation. ... the better understanding of biology can its related ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web hosting ... Top10BestSEOHosting.com is here to announce that JustHost, Bluehost ... in 2014. , JustHost ( http://www.justhost.com/track/seohosts ) provides ... hosting plan. The company’s approach to hosting is ... accessible and powerful enough for anyone to use. ...
Breaking Medicine News(10 mins):Health News:Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research 2Health News:Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research 3Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2
... in the body, it could replace traditional metal stents , , ... is quietly absorbed by the body after it has done ... well in an international trial, researchers report. , The stent ... said. In a one-year follow-up, none of the arteries in ...
... older adults, safety advocates and health,professionals today called for ... Control and Prevention (CDC) to address the growing,large-scale problem ... in three older Americans (65 and older) falls and ... most recent data shows,that 1.8 million older adults were ...
... State Funded Lung Cancer Research Bill Given Hearing ... Today, Lung Cancer,Alliance praised the efforts of ... cancer research funding bill through the,Massachusetts State Senate ... "trust fund," known as the Commonwealth Lung Cancer ...
... healthy food for your family, but if the good grocery ... are cheap and plentiful, it may be harder to make ... and funded by the Canadian Institute for Health Information confirms ... we are to struggle with obesity. , The startling ...
... Guidance Remains Unchanged and is Updated to Reflect,On- ... Rate Effects of Separation, BATESVILLE, Ind., March ... filed materials with the Securities and,Exchange Commission (SEC) ... of its two operating companies: Hill-Rom, the,company,s medical ...
... - Product Sales of $90 Million to $120 Million Expected in ... by Year End, - New Data Provided on Pipeline ... ... Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) today provided a comprehensive ...
Cached Medicine News:Health News:Melt-Away Stent Works Well in Trial 2Health News:Melt-Away Stent Works Well in Trial 3Health News:30 National Organizations Issue Call to Action for Congress to Fully Fund Falls Prevention Programming in CDC Budget 2Health News:30 National Organizations Issue Call to Action for Congress to Fully Fund Falls Prevention Programming in CDC Budget 3Health News:Lung Cancer Alliance Commends Leadership of MA State Senate 2Health News:Urban planning a factor in rising obesity rates, says new report 2Health News:Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket 2Health News:Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket 3Health News:Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket 4Health News:Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket 5Health News:Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket 6Health News:Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket 7Health News:Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket 8Health News:Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation 2Health News:Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation 3Health News:Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation 4Health News:Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation 5Health News:Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation 6
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: